AIC
UTHR icon

Archer Investment Corporation’s United Therapeutics UTHR Stock Holding History

Archer Investment Corporation’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Hold
519
– – 0.05% 291
2026
Q1 		$308K Buy
519
+100
+24% +$49.8K 0.07% 234
2025
Q4 		$204K Buy
419
+63
+18% +$29.3K 0.05% 265
2025
Q3 		$149K Buy
356
+31
+10% +$10.4K 0.03% 325
2025
Q2 		$93.4K Sell
325
-790
-71% -$236K 0.02% 384
2025
Q1 		$344K Buy
1,115
+325
+41% +$111K 0.09% 186
2024
Q4 		$279K Hold
790
– – 0.07% 201
2024
Q3 		$283K Buy
+790
New +$267K 0.08% 198
2024
Q1 		– Sell
-229
Closed -$50.4K – 1109
2023
Q4 		$50.4K Hold
229
– – 0.02% 398
2023
Q3 		$51.7K Hold
229
– – 0.02% 377
2023
Q2 		$50.6K Hold
229
– – 0.02% 381
2023
Q1 		$51.6K Buy
+229
New +$56.5K 0.02% 382

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Archer Investment Corporation's UTHR Position: Q2 2026 in Review

Archer Investment Corporation held its United Therapeutics (UTHR) position steady in Q2 2026 at 519 shares worth $281K. The position accounts for 0.05% of the portfolio, ranked #291.

Archer Investment Corporation first reported a position in UTHR in Q1 2023 and has held it in 12 quarters since. The position peaked at $344K in Q1 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Archer Investment Corporation held 519 shares of United Therapeutics worth $281K as of Q2 2026.
  • Archer Investment Corporation left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.05% of Archer Investment Corporation's portfolio in Q2 2026, its #291 holding.
  • Archer Investment Corporation first reported a position in United Therapeutics in Q1 2023 and has held it in 12 quarters since.
  • Archer Investment Corporation's United Therapeutics position peaked at $344K in Q1 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.